Lancet (London, England) Voysey, M, Clemens, S A C, Madhi, S A, Weckx, L Y, Folegatti, P M, Aley, P K, Angus, B, Baillie, V L, Barnabas, S L, Bhorat, Q E, Bibi, S, Briner, C, Cicconi, P, Collins, A M, Colin-Jones, R, Cutland, C L, Darton, T C, Dheda, K, Duncan, C J A, Emary, K R W, Ewer, K J, Fairlie, L, Faust, S N, Feng, S, Ferreira, D M, Finn, A, Goodman, A L, Green, C M, Green, C A, Heath, P T, Hill, C, Hill, H, Hirsch, I, Hodgson, S H C, Izu, A, Jackson, S, Jenkin, D, Joe, C C D, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, A M, Lelliott, A, Libri, V, Lillie, P J, Mallory, R, Mendes, A V A, Milan, E P, Minassian, A M, McGregor, A, Morrison, H, Mujadidi, Y F, Nana, A, O'Reilly, P J, Padayachee, S D, Pittella, A, Plested, E, Pollock, K M, Ramasamy, M N, Rhead, S, Schwarzbold, A V, Singh, N, Smith, A, Song, R, Snape, M D, Sprinz, E, Sutherland, R K, Tarrant, R, Thomson, E C, Török, M E, Toshner, M, Turner, D P J, Vekemans, J, Villafana, T L, Watson, M E E, Williams, C J, Douglas, A D, Hill, A V S, Lambe, T & Gilbert, S C & Pollard, A J 2021, ' Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK ', The Lancet, vol. 397, no. 10269, pp. 99-111 . https://doi.org/10.1016/S0140-6736(20)32661-1 The Lancet Voysey, M, Clemens, S A C, Madhi, S A, Weckx, L Y, Folegatti, P M, Aley, P K, Angus, B, Baillie, V L, Barnabas, S L, Bhorat, Q E, Bibi, S, Briner, C, Cicconi, P, Collins, A M, Colin-Jones, R, Cutland, C L, Darton, T C, Dheda, K, Duncan, C J A, Emary, K R W, Ewer, K J, Fairlie, L, Faust, S N, Feng, S, Ferreira, D M, Finn, A, Goodman, A L, Green, C M, Green, C A, Heath, P T, Hill, C, Hill, H, Hirsch, I, Hodgson, S H C, Izu, A, Jackson, S, Jenkin, D, Joe, C C D, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, A M, Lelliott, A, Libri, V, Lillie, P J, Mallory, R, Smith, A, Pollard, A J, Hyams, C & Abeysekera, K W M 2021, ' Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK ', Lancet, vol. 397, no. 10269, pp. 99-111 . https://doi.org/10.1016/S0140-6736(20)32661-1, https://doi.org/10.1016/s0140-6736(20)32661-1 Virologica Sinica
Nature Microbiology Seow, J, Graham, C, Merrick, B, Acors, S, Pickering, S, Steel, K J A, Hemmings, O, O’Byrne, A, Kouphou, N, Galao, R P, Betancor, G, Wilson, H D, Signell, A W, Winstone, H, Kerridge, C, Huettner, I, Jimenez-Guardeño, J M, Lista, M J, Temperton, N, Snell, L B, Bisnauthsing, K, Moore, A, Green, A, Martinez, L, Stokes, B, Honey, J, Izquierdo-Barras, A, Arbane, G, Patel, A, Tan, M K I, O’Connell, L, O’Hara, G, MacMahon, E, Douthwaite, S, Nebbia, G, Batra, R, Martinez-Nunez, R, Shankar-Hari, M, Edgeworth, J D, Neil, S J D, Malim, M H & Doores, K J 2020, ' Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans ', Nature Microbiology, vol. 5, no. 12, pp. 1598-1607 . https://doi.org/10.1038/s41564-020-00813-8 Nat Microbiol Nature microbiology, 5(12), 1598-1607. Nature Publishing Group
PLoS pathogens, 16(9). Public Library of Science Pickering, S, Betancor, G, Galão, R P, Merrick, B, Signell, A W, Wilson, H D, Kia Ik, M T, Seow, J, Graham, C, Acors, S, Kouphou, N, Steel, K J A, Hemmings, O, Patel, A, Nebbia, G, Douthwaite, S, O'Connell, L, Luptak, J, McCoy, L E, Brouwer, P, van Gils, M J, Sanders, R W, Martinez Nunez, R, Bisnauthsing, K, O'Hara, G, MacMahon, E, Batra, R, Malim, M H, Neil, S J D, Doores, K J & Edgeworth, J D 2020, ' Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings ', PLoS Pathogens, vol. 16, no. 9, e1008817 . https://doi.org/10.1371/journal.ppat.1008817 PLoS Pathogens PLoS Pathogens, Vol 16, Iss 9, p e1008817 (2020)